Features	Complete_Match (CM)	Predicted_Match (PM)	Total (CM+PM)	Weighted_Sum (WS)
Sum_of_Frequency	0.008188773637473301	0.14625709906391549	0.1544458727013888	0.0374401934502564
Weight	1.0	0.2	-	-
----------	----------	----------	----------	----------
Rank	CM:Top_Epitopes (sum_of_freq, %)	PM:Top_Epitopes (sum_of_freq, %)	TOTAL:Top_Epitopes (sum_of_freq, %)	WS:Top_Epitopes (sum_of_freq, %)
1	KLGGALQAK [IE1->CMV] (0.00194, 23.73%)	KLGGALQAK [IE1->CMV] (0.02509, 17.15%)	KLGGALQAK [IE1->CMV] (0.02703, 17.5%)	KLGGALQAK [IE1->CMV] (0.00696, 18.59%)
2	VLAWLYAAV [ORF1ab->SARS-CoV2] (0.00124, 15.1%)	FKVSIWNLDY,ILLIIMRTFK,ILLIIMRTFKVSIWNLDYII,IMRTFKVSI,KVSIWNLDY,KVSIWNLDYI,LIIMRTFKV,RTFKVSIWNL,SIWNLDYII,TFKVSIWNL,VSIWNLDYII [ORF6->SARS-CoV2] (0.01143, 7.81%)	FKVSIWNLDY,ILLIIMRTFK,ILLIIMRTFKVSIWNLDYII,IMRTFKVSI,KVSIWNLDY,KVSIWNLDYI,LIIMRTFKV,RTFKVSIWNL,SIWNLDYII,TFKVSIWNL,VSIWNLDYII [ORF6->SARS-CoV2] (0.01153, 7.46%)	AFLLFLVLI,FLAFLLFLV,FYLCFLAFL,FYLCFLAFLL,IDFYLCFLAF,IELSLIDFYL,LIDFYLCFL,LLFLVLIML,MIELSLIDFY,SLIDFYLCFL,YLCFLAFLL [ORF7b->SARS-CoV2] (0.00261, 6.97%)
3	AFLLFLVLI,FLAFLLFLV,FYLCFLAFL,FYLCFLAFLL,IDFYLCFLAF,IELSLIDFYL,LIDFYLCFL,LLFLVLIML,MIELSLIDFY,SLIDFYLCFL,YLCFLAFLL [ORF7b->SARS-CoV2] (0.00098, 12.03%)	AFLLFLVLI,FLAFLLFLV,FYLCFLAFL,FYLCFLAFLL,IDFYLCFLAF,IELSLIDFYL,LIDFYLCFL,LLFLVLIML,MIELSLIDFY,SLIDFYLCFL,YLCFLAFLL [ORF7b->SARS-CoV2] (0.00813, 5.56%)	AFLLFLVLI,FLAFLLFLV,FYLCFLAFL,FYLCFLAFLL,IDFYLCFLAF,IELSLIDFYL,LIDFYLCFL,LLFLVLIML,MIELSLIDFY,SLIDFYLCFL,YLCFLAFLL [ORF7b->SARS-CoV2] (0.00912, 5.9%)	MIELSLIDFYLCFLAFLLFLVLIML [ORF7b->SARS-CoV2] (0.00248, 6.62%)
4	MIELSLIDFYLCFLAFLLFLVLIML [ORF7b->SARS-CoV2] (0.00088, 10.74%)	MIELSLIDFYLCFLAFLLFLVLIML [ORF7b->SARS-CoV2] (0.00799, 5.47%)	MIELSLIDFYLCFLAFLLFLVLIML [ORF7b->SARS-CoV2] (0.00887, 5.74%)	FKVSIWNLDY,ILLIIMRTFK,ILLIIMRTFKVSIWNLDYII,IMRTFKVSI,KVSIWNLDY,KVSIWNLDYI,LIIMRTFKV,RTFKVSIWNL,SIWNLDYII,TFKVSIWNL,VSIWNLDYII [ORF6->SARS-CoV2] (0.00239, 6.38%)
5	LLTDEMIAQY,LTDEMIAQY,LTDEMIAQYT,VLPPLLTDEMIAQY,VLPPLLTDEMIAQYT [surface glycoprotein->SARS-CoV2] (0.00055, 6.74%)	HTTDPSFLGRY [ORF1ab->SARS-CoV2] (0.00778, 5.32%)	HTTDPSFLGRY [ORF1ab->SARS-CoV2] (0.0082, 5.31%)	HTTDPSFLGRY [ORF1ab->SARS-CoV2] (0.00197, 5.26%)
6	FLQSINFVR,FLQSINFVRI,FLYLYALVYF,GLEAPFLYLY,INFVRIIMR,LQSINFVRI,LQSINFVRII,QSINFVRII,SINFVRIIMR,VYFLQSINF,VYFLQSINFV,YFLQSINFVR,YLYALVYFL [ORF3a->SARS-CoV2] (0.00051, 6.28%)	FLWLLWPVT,FLWLLWPVTL,FLWLLWPVTLACFVLAAV,LWLLWPVTL,LWPVTLACF,TLACFVLAAV,WLLWPVTLA,WPVTLACFVL [membrane glycoprotein->SARS-CoV2] (0.0068, 4.65%)	FLWLLWPVT,FLWLLWPVTL,FLWLLWPVTLACFVLAAV,LWLLWPVTL,LWPVTLACF,TLACFVLAAV,WLLWPVTLA,WPVTLACFVL [membrane glycoprotein->SARS-CoV2] (0.00705, 4.56%)	FLWLLWPVT,FLWLLWPVTL,FLWLLWPVTLACFVLAAV,LWLLWPVTL,LWPVTLACF,TLACFVLAAV,WLLWPVTLA,WPVTLACFVL [membrane glycoprotein->SARS-CoV2] (0.0016, 4.28%)
7	NLVPMVATV [pp65->CMV] (0.00044, 5.4%)	LVVDFSQFSR [DNA polymerase->HBV] (0.00675, 4.61%)	LVVDFSQFSR [DNA polymerase->HBV] (0.00675, 4.37%)	FVDGVPFVV [ORF1ab->SARS-CoV2] (0.00153, 4.08%)
8	HTTDPSFLGRY [ORF1ab->SARS-CoV2] (0.00041, 5.05%)	YVLDHLIVV [BRLF1->EBV] (0.0062, 4.24%)	YVLDHLIVV [BRLF1->EBV] (0.00632, 4.09%)	NLVPMVATV [pp65->CMV] (0.00142, 3.8%)
9	AFPFTIYSL,GYINVFAFPF,INVFAFPFTI,MGYINVFAF,MGYINVFAFPFTIYSL,NVFAFPFTI,NVFAFPFTIY,YINVFAFPF [ORF10->SARS-CoV2] (0.00039, 4.81%)	FVDGVPFVV [ORF1ab->SARS-CoV2] (0.00585, 4.0%)	FVDGVPFVV [ORF1ab->SARS-CoV2] (0.00621, 4.02%)	YVLDHLIVV [BRLF1->EBV] (0.00136, 3.63%)
10	FVDGVPFVV [ORF1ab->SARS-CoV2] (0.00036, 4.34%)	NLVPMVATV [pp65->CMV] (0.0049, 3.35%)	NLVPMVATV [pp65->CMV] (0.00534, 3.46%)	LVVDFSQFSR [DNA polymerase->HBV] (0.00135, 3.6%)
11	ALALLLLDR,GDAALALLLL,GDAALALLLLDRLNQL,LALLLLDRL,LLLDRLNQL,LLLLDRLNQ,LLLLDRLNQL [nucleocapsid phosphoprotein->SARS-CoV2] (0.00033, 4.04%)	FGEVFNATRF,FNATRFASVY,GEVFNATRF,NATRFASVY [surface glycoprotein->SARS-CoV2] (0.00384, 2.63%)	FGEVFNATRF,FNATRFASVY,GEVFNATRF,NATRFASVY [surface glycoprotein->SARS-CoV2] (0.00384, 2.49%)	VLAWLYAAV [ORF1ab->SARS-CoV2] (0.00124, 3.3%)
12	AVFDRKSDAK [EBNA4->EBV] (0.00031, 3.75%)	KLSYGIATV [ORF1ab->SARS-CoV2] (0.00384, 2.62%)	KLSYGIATV [ORF1ab->SARS-CoV2] (0.00384, 2.48%)	GILGFVFTL [M->Influenza] (0.00087, 2.34%)
13	ELAGIGILTV [MLANA->Homo sapiens] (0.0003, 3.64%)	FGEVFNATRFASVY [surface glycoprotein->SARS-CoV2] (0.00361, 2.47%)	FGEVFNATRFASVY [surface glycoprotein->SARS-CoV2] (0.00361, 2.34%)	FGEVFNATRF,FNATRFASVY,GEVFNATRF,NATRFASVY [surface glycoprotein->SARS-CoV2] (0.00077, 2.05%)
14	STGSNVFQTR,TGSNVFQTR,TPINLVRDL,VYSTGSNVF,VYSTGSNVFQTR [surface glycoprotein->SARS-CoV2] (0.00027, 3.35%)	GILGFVFTL [M->Influenza] (0.00315, 2.16%)	GILGFVFTL [M->Influenza] (0.0034, 2.2%)	KLSYGIATV [ORF1ab->SARS-CoV2] (0.00077, 2.05%)
15	FLYNLLTRV [SEC24A->Homo sapiens] (0.00026, 3.2%)	AEAELAKNVSL,AELAKNVSLDNVL [ORF1ab->SARS-CoV2] (0.00288, 1.97%)	GLCTLVAML [BMLF1->EBV] (0.00299, 1.94%)	FGEVFNATRFASVY [surface glycoprotein->SARS-CoV2] (0.00072, 1.93%)
16	GILGFVFTL [M->Influenza] (0.00024, 2.98%)	TPRVTGGGAM [pp65->CMV] (0.00286, 1.96%)	AEAELAKNVSL,AELAKNVSLDNVL [ORF1ab->SARS-CoV2] (0.00288, 1.86%)	GLCTLVAML [BMLF1->EBV] (0.00072, 1.92%)
17	FLWLLWPVT,FLWLLWPVTL,FLWLLWPVTLACFVLAAV,LWLLWPVTL,LWPVTLACF,TLACFVLAAV,WLLWPVTLA,WPVTLACFVL [membrane glycoprotein->SARS-CoV2] (0.00024, 2.94%)	GLCTLVAML [BMLF1->EBV] (0.00285, 1.95%)	TPRVTGGGAM [pp65->CMV] (0.00286, 1.85%)	AFPFTIYSL,GYINVFAFPF,INVFAFPFTI,MGYINVFAF,NVFAFPFTI,NVFAFPFTIY,YINVFAFPF [ORF10->SARS-CoV2] (0.0007, 1.88%)
18	GLEAPFLYLYALVYFLQSINFVRIIMR [ORF3a->SARS-CoV2] (0.00023, 2.77%)	LPRRSGAAGA [Nucleocapsid protein->Influenza] (0.0027, 1.85%)	LPRRSGAAGA [Nucleocapsid protein->Influenza] (0.0027, 1.75%)	MGYINVFAFPFTIYSL [ORF10->SARS-CoV2] (0.0006, 1.62%)
19	FLNGSCGSV [ORF1ab->SARS-CoV2] (0.00022, 2.71%)	GTITVEELK [membrane glycoprotein->SARS-CoV2] (0.0025, 1.71%)	GTITVEELK [membrane glycoprotein->SARS-CoV2] (0.0025, 1.62%)	FLNGSCGSV [ORF1ab->SARS-CoV2] (0.00059, 1.57%)
20	QIKVRVDMV [IE1->CMV] (0.00022, 2.67%)	LLYDANYFL,LLYDANYFLC,LYDANYFLCW,NPLLYDANY,NPLLYDANYFLCW,PLLYDANYFL,YDANYFLCW [ORF3a->SARS-CoV2] (0.00188, 1.28%)	FLNGSCGSV [ORF1ab->SARS-CoV2] (0.00205, 1.33%)	AEAELAKNVSL,AELAKNVSLDNVL [ORF1ab->SARS-CoV2] (0.00058, 1.54%)
21	FLPRVFSAV,FPPTSFGPL [ORF1ab->SARS-CoV2] (0.00018, 2.18%)	FLNGSCGSV [ORF1ab->SARS-CoV2] (0.00183, 1.25%)	AFPFTIYSL,GYINVFAFPF,INVFAFPFTI,MGYINVFAF,NVFAFPFTI,NVFAFPFTIY,YINVFAFPF [ORF10->SARS-CoV2] (0.00194, 1.26%)	TPINLVRDL [surface glycoprotein->SARS-CoV2] (0.00057, 1.53%)
22	FVCNLLLLFV,FVCNLLLLFVTVYSHLLLV,LLFVTVYSHL,LLLGIGILV,TVYSHLLLV [ORF3a->SARS-CoV2] (0.00017, 2.12%)	SEHDYQIGGYTEKW,YQIGGYTEK,YQIGGYTEKW [ORF3a->SARS-CoV2] (0.00175, 1.2%)	LLYDANYFL,LLYDANYFLC,LYDANYFLCW,NPLLYDANY,NPLLYDANYFLCW,PLLYDANYFL,YDANYFLCW [ORF3a->SARS-CoV2] (0.00188, 1.22%)	TPRVTGGGAM [pp65->CMV] (0.00057, 1.53%)
23	ILGTVSWNL,RAKFKQLL,SNEKQEILGTVSW,SNEKQEILGTVSWNL [ORF1ab->SARS-CoV2] (0.00015, 1.88%)	KAYNVTQAF [nucleocapsid phosphoprotein->SARS-CoV2] (0.00167, 1.14%)	TPINLVRDL [surface glycoprotein->SARS-CoV2] (0.00177, 1.14%)	LLTDEMIAQY,LTDEMIAQY,LTDEMIAQYT,VLPPLLTDEMIAQY,VLPPLLTDEMIAQYT [surface glycoprotein->SARS-CoV2] (0.00055, 1.48%)
24	GLCTLVAML [BMLF1->EBV] (0.00015, 1.81%)	RQLLFVVEV [ORF1ab->SARS-CoV2] (0.00159, 1.09%)	SEHDYQIGGYTEKW,YQIGGYTEK,YQIGGYTEKW [ORF3a->SARS-CoV2] (0.00175, 1.13%)	LPRRSGAAGA [Nucleocapsid protein->Influenza] (0.00054, 1.44%)
25	APKEIIFL,APKEIIFLEGETL,ILGLPTQTV,KEIIFLEGETL [ORF1ab->SARS-CoV2] (0.00014, 1.76%)	GMEVTPSGTWL,GMEVTPSGTWLTY,MEVTPSGTWL,TPSGTWLTY,VTPSGTWLTY [nucleocapsid phosphoprotein->SARS-CoV2] (0.00156, 1.06%)	KAYNVTQAF [nucleocapsid phosphoprotein->SARS-CoV2] (0.00167, 1.08%)	ELAGIGILTV [MLANA->Homo sapiens] (0.00053, 1.43%)
26	ELYSPIFLI,LYSPIFLIV,QELYSPIFL,VQELYSPIF,VQELYSPIFL,VQELYSPIFLIV [ORF7a->SARS-CoV2] (0.00013, 1.65%)	FADDLNQLTGY [ORF1ab->SARS-CoV2] (0.00155, 1.06%)	FVCNLLLLFV,FVCNLLLLFVTVYSHLLLV,LLFVTVYSHL,TVYSHLLLV [ORF3a->SARS-CoV2] (0.00163, 1.05%)	FLQSINFVR,FLQSINFVRI,FLYLYALVYF,GLEAPFLYLY,INFVRIIMR,LQSINFVRI,LQSINFVRII,QSINFVRII,SINFVRIIMR,VYFLQSINF,VYFLQSINFV,YFLQSINFVR,YLYALVYFL [ORF3a->SARS-CoV2] (0.00051, 1.37%)
27	GEIPVAYRKVLL,GVYDYLVST,KTSVDCTMYI,LLWNGPMAV,TLGVYDYLV,TLGVYDYLVST,VPHVGEIPVAY,VPHVGEIPVAYRKVLL [ORF1ab->SARS-CoV2] (0.00013, 1.55%)	AFPFTIYSL,GYINVFAFPF,INVFAFPFTI,MGYINVFAF,NVFAFPFTI,NVFAFPFTIY,YINVFAFPF [ORF10->SARS-CoV2] (0.00154, 1.06%)	RQLLFVVEV [ORF1ab->SARS-CoV2] (0.00159, 1.03%)	GTITVEELK [membrane glycoprotein->SARS-CoV2] (0.0005, 1.34%)
28	SYFTSDYYQL,VLHSYFTSDY,YFTSDYYQLY [ORF3a->SARS-CoV2] (0.00012, 1.52%)	LYNSASFSTF,NSASFSTFK,SVLYNSASF,YSVLYNSASF,YSVLYNSASFSTFK [surface glycoprotein->SARS-CoV2] (0.00151, 1.03%)	GMEVTPSGTWL,GMEVTPSGTWLTY,MEVTPSGTWL,TPSGTWLTY,VTPSGTWLTY [nucleocapsid phosphoprotein->SARS-CoV2] (0.00156, 1.01%)	FVCNLLLLFV,FVCNLLLLFVTVYSHLLLV,LLFVTVYSHL,TVYSHLLLV [ORF3a->SARS-CoV2] (0.00046, 1.24%)
29	FERDISTEI,FERDISTEIY,KPFERDISTEI,KPFERDISTEIY [surface glycoprotein->SARS-CoV2] (0.00012, 1.47%)	TPINLVRDL [surface glycoprotein->SARS-CoV2] (0.00149, 1.02%)	FADDLNQLTGY [ORF1ab->SARS-CoV2] (0.00155, 1.0%)	STGSNVFQTR,TGSNVFQTR,VYSTGSNVF,VYSTGSNVFQTR [surface glycoprotein->SARS-CoV2] (0.00046, 1.22%)
30	YVLDHLIVV [BRLF1->EBV] (0.00012, 1.45%)	FVCNLLLLFV,FVCNLLLLFVTVYSHLLLV,LLFVTVYSHL,TVYSHLLLV [ORF3a->SARS-CoV2] (0.00146, 0.99%)	LYNSASFSTF,NSASFSTFK,SVLYNSASF,YSVLYNSASF,YSVLYNSASFSTFK [surface glycoprotein->SARS-CoV2] (0.00151, 0.98%)	AVFDRKSDAK [EBNA4->EBV] (0.00042, 1.13%)
